Response to: Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?

Affiliations

¹ Department of Gynecology and Obstetrics, Innsbruck Medical University, Innsbruck, Austria nicole.concin@i-med.ac.at.
² Department of Gynecology and Gynecological Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany.
³ Department of Pathology, Hospital Universitari Arnau de Vilanova, University of Lleida, CIBERONC, Irblleida, Spain.
⁴ Department of Pathology, Hospital Universitari de Bellvitge, University of Barcelona, Idibell, Spain.
⁵ Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands.

Free article

Comment

Nicole Concin et al. Int J Gynecol Cancer. 2021 Jun.

Free article

. 2021 Jun;31(6):947.

doi: 10.1136/ijgc-2021-002668. Epub 2021 Apr 28.

¹ Department of Gynecology and Obstetrics, Innsbruck Medical University, Innsbruck, Austria nicole.concin@i-med.ac.at.
² Department of Gynecology and Gynecological Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany.
³ Department of Pathology, Hospital Universitari Arnau de Vilanova, University of Lleida, CIBERONC, Irblleida, Spain.
⁴ Department of Pathology, Hospital Universitari de Bellvitge, University of Barcelona, Idibell, Spain.
⁵ Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands.

No abstract available

Keywords: endometrial neoplasms.

Conflict of interest statement

Competing interests: None declared.

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann J, Bosse T, Chargari C, Fagotti A, Fotopoulou C, Gonzalez Martin A, Lax S, Lorusso D, Marth C, Morice P, Nout RA, O'Donnell D, Querleu D, Raspollini MR, Sehouli J, Sturdza A, Taylor A, Westermann A, Wimberger P, Colombo N, Planchamp F, Creutzberg CL. Concin N, et al. Int J Gynecol Cancer. 2021 Jan;31(1):12-39. doi: 10.1136/ijgc-2020-002230. Epub 2020 Dec 18. Int J Gynecol Cancer. 2021. PMID: 33397713
Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?
Merlotti A, Russi E, De Sanctis V. Merlotti A, et al. Int J Gynecol Cancer. 2021 Jun;31(6):946. doi: 10.1136/ijgc-2021-002630. Epub 2021 Apr 28. Int J Gynecol Cancer. 2021. PMID: 33911003 No abstract available.